National naloxone programme Scotland - Quarterly monitoring bulletin
Quarterly Monitoring Bulletin April to June (Q1) 2022/23
A Management Information Statistics publication for Scotland
- Published
- 06 December 2022
- Type
- Statistical report
- Author
- Public Health Scotland
About this release
This release by Public Health Scotland (PHS) presents information on the number of take-home naloxone kits issued by the National Naloxone Programme (NNP) in Scotland. Figures are presented separately for kits issued from community outlets, kits issued in prisons at the point of liberation, kits dispensed via community prescription, and kits issued by Scottish Ambulance Service (SAS).
Accidental overdose is a common cause of death among users of heroin, morphine and similar drugs, which are referred to as opioids. Naloxone is a drug which reverses the effects of a potentially fatal overdose with these drugs.
Main points
During 2022/23 Quarter 1 (1 April 2022 to 30 June 2022):
- 6,549 Take-Home Naloxone (THN) kits were issued.
- 4,931 THN kits were issued by services based in the community.
- Community THN supplies included 1,268 kits issued by non-drug treatment services. Of these, 87% (1,098) were supplied by Scottish Families Affected by Alcohol & Drugs (SFAD).
- 412 kits were issued by prisons in Scotland.
- 793 kits were dispensed by community pharmacies.
- 392 THN kits were provided by the Scottish Ambulance Service.
At the end of 2022/23 Quarter 1, the 'reach' of the NNP (percentage of people at risk of opioid overdose who have been supplied with THN) was estimated to be 66.1% – an increase of 1.3 percentage points compared to 2021/22 Quarter 4 (64.8%).
Background
The overall aim of Scotland’s NNP is to prevent fatal opioid overdoses. Administration of naloxone provides time for emergency services to arrive and for further treatment to be given. Following suitable training, THN kits are issued to people at risk of opioid overdose, their friends and family and service workers in order to help prevent overdose deaths. For more information on the background of the NNP and for a definition of 'reach', see Appendix 1 in the National Naloxone Programme Scotland Annual Report.
Further information
The next release of this publication will be 7 March 2023.
General enquiries
If you have an enquiry relating to this publication, please email phs.drugsteam@phs.scot.
Media enquiries
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email phs.otherformats@phs.scot.
To report any issues with a publication, please email phs.generalpublications@phs.scot.
Older versions of this publication
Versions of this publication released before 16 March 2020 may be found on the Data and Intelligence, Health Protection Scotland or Improving Health websites.